Home Tags Human Simplex Virus (HSV 2)

Tag: Human Simplex Virus (HSV 2)

A revolution in nanotech helps create a new vaccine delivery system that could literally...

The Nanopatch, a revolutionary new needle-free device for delivering vaccines, has won a $15 million capital injection (pun intended), but also was an award winner at World Vaccine Congress. After eight years of research, the Nanopatch looks set to revolutionise vaccination delivery forever.

Queensland biotech startup Vaxxas gets $15 million from venture funds

Vaxxas Pty. Ltd. has won a $15 million investment from venture groups led by OneVentures. Other investors include Brandon Capital Partners, the Medical Research Commercialisation Fund and U.S.-based HealthCare Ventures. Vaxxas is the first Queensland company to be funded under the Bio Capital Fund, which has swelled to nearly $250 million, established last year with the help of Health Care Ventures and Eli Lilly, among others. The investment was negotiated in the main by UniQuest Pty Limited, the University of Queensland’s main commercialisation company.
Subscribe to the Newsletter Over 30K subscribers

FREE BUSINESS TOOLS

Generating Web Traffic with Mark Middo and James Tuckerman [FREE REPORT]

Not all websites are created equal. That’s the first – and perhaps harshest – lesson when venturing into the ever evolving world of online marketing. Websites don’t draw visitors just by existing; they require love, attention and an understanding of how search engines think. In this Cheat Sheet, Anthill Magazine’s James Tuckerman and guest Mark “Middo” Middleton share their combined wisdom on generating web traffic for new and old websites.

FREE BUSINESS TOOL

INFOGRAPHICS

New Zealand’s Xero eyes US IPO, further disruption as subscribers increase...

Xero recently held its annual meeting in Wellington, during which the company revealed some interesting details about its future. As has been widely suspected, the...

OPINIONS & ADVICE